ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
iSpecimen Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.91−0.01 (-0.75%)
Close on Oct 19, 2026
- Market cap
- $1.27M
- P/E (TTM)
- –
- Dividend yield
- –
iSpecimen Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Specimens - contracts with customers [Member] | $125.44K | $134.41K | – | $95.82K | $671.69K | $976.97K | $1.35M | $2.63M | $2.84M | $2.14M | $2.49M | $2.64M | 82.6% | -81.3% |
| Shipping and other [Member] | $26.51K | $21.60K | $61.24K | $10.78K | $41.44K | $80.54K | $124.90K | $35.03K | $28.23K | $153.89K | $88.16K | $137.45K | 17.4% | -36.0% |
By region
From the segment and revenue-disaggregation notes of iSpecimen's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.